ADMA Biologics is trading 4.07% higher at $11.12 on October 26, 2026, with higher U.S. indexes potentially supportive; no direct cause has been established.
- No fresh company-specific announcement or catalyst explaining the move surfaced in the search; the latest company release was an October 15 publication announcement.
- The S&P 500 is up 0.88% and the Nasdaq Composite is up 1.24%, alongside the gain.